Dynamic modulations of sphingolipids and glycerophospholipids in COVID-19
Article
[키워드] Administered
association
biological properties
Biomarker
ceramide
characteristic
clinical phenotype
conditions
control subject
coronavirus disease
Course
COVID-19
Critical
CRP
D-dimer
decrease
develop
disease severity
dynamic
early phase
glycerophospholipids
heterogeneity
heterogeneous
Infectious disease
Laboratory testing
Lipidomics
lysophosphatidylcholine
mechanism
mice
modulation
negative correlation
Phosphatidylcholine
positive
Prevent
responsible
serum
severe COVID-19
severity
shown
sphingolipid
sphingolipids
sphingomyelin
subject
subjects
suppress
tissue
treated
unsaturated
[DOI] 10.1002/ctm2.1069 PMC 바로가기
[DOI] 10.1002/ctm2.1069 PMC 바로가기